CREATeTM
New class of CNS medication employing a small molecule-controlled gene therapy. Development of a modified receptor that allows pharmaceutical targeting of specific neuronal populations. CREATE Therapeutics is a spin-off venture of VRG Therapeutics.
CREATeTM
Chemogenetic Receptor Engineering for Advanced Therapeutics
01
CREATe-1
Various CNS
diseases
02
CREATeTM technology
Original receptor:
  • expressed on neurons
  • when activated, affects (inhibits of excitates) the activity of neuron it is expressed on
  • Activated by its endogenous ligand (produced by another neuron)
  • May have some level of constitutive activity (without ligand)
Modified receptor (CREATeTM):
  • Expressed on specific neurons (defined by location and/or neurochemical attributes)
  • No constitutive activity
  • Does not bind its endogenous ligand (therefore not activated by it)
  • Activated by an exogenous drug (actuator)
Medical benefits:
  • Offers a safer alternative for some neurosurgery techniques (deep brain stimulation, lesion)
  • Effect can be fine-tuned (by actuator dose and timing), even temporarily or terminally eliminated (if no actuator is given)
  • Exact targeting better safety/efficacy profile then existing CNS therapies
01
CREATe-1
Various CNS
diseases
02
CREATeTM technology
Original receptor:
  • expressed on neurons
  • when activated, affects (inhibits of excitates) the activity of neuron it is expressed on
  • Activated by its endogenous ligand (produced by another neuron)
  • May have some level of constitutive activity (without ligand)
Modified receptor (CREATeTM):
  • Expressed on specific neurons (defined by location and/or neurochemical attributes)
  • No constitutive activity
  • Does not bind its endogenous ligand (therefore not activated by it)
  • Activated by an exogenous drug (actuator)
Medical benefits:
  • Offers a safer alternative for some neurosurgery techniques (deep brain stimulation, lesion)
  • Effect can be fine-tuned (by actuator dose and timing), even temporarily or terminally eliminated (if no actuator is given)
  • Exact targeting better safety/efficacy profile then existing CNS therapies
Learn More
Million ways to improve life
Learn More
Million ways to improve life